Trial: 202111071

A Phase I/II, Dose-Escalation study of MGTA-117 in patients with Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)

Phase

I/II (Cancer Control)

Principal Investigator

Westervelt, Peter

Disease Site

Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS); Myeloid and Monocytic Leukemia; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov